<antigenSupportingData>
<immunity>
<clinicalHistory>
<guidelineCode>019</guidelineCode>
<guidelineTitle>Laboratory Evidence of Immunity or confirmation of Hepatitis B disease</guidelineTitle>
</clinicalHistory>
</immunity>
<contraindications>
<vaccineGroup>
<contraindication>
<observationCode>097</observationCode>
<observationTitle>Severe allergic reaction after previous dose of Hepatitis B</observationTitle>
<contraindicationText>Do not vaccinate if the patient has had a severe allergic reaction after a previous dose of Hepatitis B vaccine.</contraindicationText>
<beginAge/>
<endAge/>
</contraindication>
<contraindication>
<observationCode>080</observationCode>
<observationTitle>Adverse reaction to vaccine component</observationTitle>
<contraindicationText>Do not vaccinate if the patient has had an adverse reaction to a vaccine component.</contraindicationText>
<beginAge/>
<endAge/>
</contraindication>
<contraindication>
<observationCode>110</observationCode>
<observationTitle>Hypersensitivity to yeast</observationTitle>
<contraindicationText>Do not vaccinate if the patient has a hypersensitivity to yeast.</contraindicationText>
<beginAge/>
<endAge/>
</contraindication>
</vaccineGroup>
<vaccine>
<contraindication>
<observationCode>107</observationCode>
<observationTitle>Severe allergic reaction to neomycin</observationTitle>
<contraindicationText>Do not vaccinate if the patient has had a severe allergic reaction to neomycin.</contraindicationText>
<contraindicatedVaccine>
<vaccineType>HepA-HepB</vaccineType>
<cvx>104</cvx>
<beginAge/>
<endAge/>
</contraindicatedVaccine>
<contraindicatedVaccine>
<vaccineType>DTaP-HepB-IPV</vaccineType>
<cvx>110</cvx>
<beginAge/>
<endAge/>
</contraindicatedVaccine>
</contraindication>
<contraindication>
<observationCode>109</observationCode>
<observationTitle>Severe allergic reaction to polymyxin B</observationTitle>
<contraindicationText>Do not vaccinate if the patient has had a severe allergic reaction to polymyxin B. </contraindicationText>
<contraindicatedVaccine>
<vaccineType>DTaP-HepB-IPV</vaccineType>
<cvx>110</cvx>
<beginAge/>
<endAge/>
</contraindicatedVaccine>
</contraindication>
</vaccine>
</contraindications>
<series>
<seriesName>Hep B 3-dose series</seriesName>
<targetDisease>HepB</targetDisease>
<vaccineGroup>HepB</vaccineGroup>
<seriesAdminGuidance/>
<seriesType>Standard</seriesType>
<equivalentSeriesGroups>2</equivalentSeriesGroups>
<requiredGender/>
<selectSeries>
<defaultSeries>Yes</defaultSeries>
<productPath>No</productPath>
<seriesGroupName>Standard</seriesGroupName>
<seriesGroup>1</seriesGroup>
<seriesPriority>A</seriesPriority>
<seriesPreference>1</seriesPreference>
<minAgeToStart/>
<maxAgeToStart>19 years</maxAgeToStart>
</selectSeries>
<indication/>
<seriesDose>
<doseNumber>Dose 1</doseNumber>
<age>
<absMinAge>0 days</absMinAge>
<minAge>0 days</minAge>
<earliestRecAge>0 days</earliestRecAge>
<latestRecAge>4 weeks</latestRecAge>
<maxAge>19 years</maxAge>
</age>
<interval/>
<allowableInterval/>
<preferableVaccine>
<vaccineType>Hep B, Adol/peds</vaccineType>
<cvx>08</cvx>
<beginAge>0 days</beginAge>
<endAge>20 years</endAge>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>Hep B, Adult</vaccineType>
<cvx>43</cvx>
<beginAge>20 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>1</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>Hep B, Dialysis</vaccineType>
<cvx>44</cvx>
<beginAge>20 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>1</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>DTaP-HepB-IPV</vaccineType>
<cvx>110</cvx>
<beginAge>6 weeks</beginAge>
<endAge>7 years</endAge>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adol/peds</vaccineType>
<cvx>08</cvx>
<beginAge>0 days</beginAge>
<endAge>20 years</endAge>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adol/high risk infant</vaccineType>
<cvx>42</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adult</vaccineType>
<cvx>43</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Dialysis</vaccineType>
<cvx>44</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Unspecified Formulation</vaccineType>
<cvx>45</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hib-HepB</vaccineType>
<cvx>51</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTP-Hib-HepB</vaccineType>
<cvx>102</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTaP-HepB-IPV</vaccineType>
<cvx>110</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTaP-IPV-Hib-HepB, historical</vaccineType>
<cvx>132</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTaP-IPV-Hib-HepB</vaccineType>
<cvx>146</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>HepA-HepB</vaccineType>
<cvx>104</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 2</doseNumber>
<age>
<absMinAge>4 weeks - 4 days</absMinAge>
<minAge>4 weeks</minAge>
<earliestRecAge>1 month</earliestRecAge>
<latestRecAge>3 months + 4 weeks</latestRecAge>
<maxAge/>
</age>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>4 weeks - 4 days</absMinInt>
<minInt>4 weeks</minInt>
<earliestRecInt>4 weeks</earliestRecInt>
<latestRecInt>5 months + 4 weeks</latestRecInt>
<intervalPriority/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>Hep B, Adol/peds</vaccineType>
<cvx>08</cvx>
<beginAge>0 days</beginAge>
<endAge>20 years</endAge>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>Hep B, Adult</vaccineType>
<cvx>43</cvx>
<beginAge>20 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>1</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>Hep B, Dialysis</vaccineType>
<cvx>44</cvx>
<beginAge>20 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>1</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>DTaP-HepB-IPV</vaccineType>
<cvx>110</cvx>
<beginAge>6 weeks</beginAge>
<endAge>7 years</endAge>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adol/peds</vaccineType>
<cvx>08</cvx>
<beginAge>0 days</beginAge>
<endAge>20 years</endAge>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adol/high risk infant</vaccineType>
<cvx>42</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adult</vaccineType>
<cvx>43</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Dialysis</vaccineType>
<cvx>44</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Unspecified Formulation</vaccineType>
<cvx>45</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hib-HepB</vaccineType>
<cvx>51</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTP-Hib-HepB</vaccineType>
<cvx>102</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTaP-HepB-IPV</vaccineType>
<cvx>110</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTaP-IPV-Hib-HepB, historical</vaccineType>
<cvx>132</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTaP-IPV-Hib-HepB</vaccineType>
<cvx>146</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>HepA-HepB</vaccineType>
<cvx>104</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 3</doseNumber>
<age>
<absMinAge>24 weeks - 4 days</absMinAge>
<minAge>24 weeks</minAge>
<earliestRecAge>6 months</earliestRecAge>
<latestRecAge>19 months + 4 weeks</latestRecAge>
<maxAge/>
</age>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>8 weeks - 4 days</absMinInt>
<minInt>8 weeks</minInt>
<earliestRecInt>8 weeks</earliestRecInt>
<latestRecInt>18 months + 4 weeks</latestRecInt>
<intervalPriority/>
</interval>
<interval>
<fromPrevious>N</fromPrevious>
<fromTargetDose>1</fromTargetDose>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>16 weeks - 4 days</absMinInt>
<minInt>16 weeks</minInt>
<earliestRecInt/>
<latestRecInt/>
<intervalPriority/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>Hep B, Adol/peds</vaccineType>
<cvx>08</cvx>
<beginAge>0 days</beginAge>
<endAge>20 years</endAge>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>Hep B, Adult</vaccineType>
<cvx>43</cvx>
<beginAge>20 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>1</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>Hep B, Dialysis</vaccineType>
<cvx>44</cvx>
<beginAge>20 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>1</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>DTaP-HepB-IPV</vaccineType>
<cvx>110</cvx>
<beginAge>6 weeks</beginAge>
<endAge>7 years</endAge>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adol/peds</vaccineType>
<cvx>08</cvx>
<beginAge>0 days</beginAge>
<endAge>20 years</endAge>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adol/high risk infant</vaccineType>
<cvx>42</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adult</vaccineType>
<cvx>43</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Dialysis</vaccineType>
<cvx>44</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Unspecified Formulation</vaccineType>
<cvx>45</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hib-HepB</vaccineType>
<cvx>51</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTP-Hib-HepB</vaccineType>
<cvx>102</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTaP-HepB-IPV</vaccineType>
<cvx>110</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTaP-IPV-Hib-HepB, historical</vaccineType>
<cvx>132</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTaP-IPV-Hib-HepB</vaccineType>
<cvx>146</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>HepA-HepB</vaccineType>
<cvx>104</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
</series>
<series>
<seriesName>Hep B 4-dose series</seriesName>
<targetDisease>HepB</targetDisease>
<vaccineGroup>HepB</vaccineGroup>
<seriesAdminGuidance/>
<seriesType>Standard</seriesType>
<equivalentSeriesGroups>2</equivalentSeriesGroups>
<requiredGender/>
<selectSeries>
<defaultSeries>No</defaultSeries>
<productPath>No</productPath>
<seriesGroupName>Standard</seriesGroupName>
<seriesGroup>1</seriesGroup>
<seriesPriority>A</seriesPriority>
<seriesPreference>2</seriesPreference>
<minAgeToStart/>
<maxAgeToStart>19 years</maxAgeToStart>
</selectSeries>
<indication/>
<seriesDose>
<doseNumber>Dose 1</doseNumber>
<age>
<absMinAge>0 days</absMinAge>
<minAge>0 days</minAge>
<earliestRecAge>0 days</earliestRecAge>
<latestRecAge>4 weeks</latestRecAge>
<maxAge>19 years</maxAge>
</age>
<interval/>
<allowableInterval/>
<preferableVaccine>
<vaccineType>Hep B, Adol/peds</vaccineType>
<cvx>08</cvx>
<beginAge>0 days</beginAge>
<endAge>20 years</endAge>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>DTaP-HepB-IPV</vaccineType>
<cvx>110</cvx>
<beginAge>6 weeks</beginAge>
<endAge>7 years</endAge>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adol/peds</vaccineType>
<cvx>08</cvx>
<beginAge>0 days</beginAge>
<endAge>20 years</endAge>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adol/high risk infant</vaccineType>
<cvx>42</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adult</vaccineType>
<cvx>43</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Dialysis</vaccineType>
<cvx>44</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Unspecified Formulation</vaccineType>
<cvx>45</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hib-HepB</vaccineType>
<cvx>51</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTP-Hib-HepB</vaccineType>
<cvx>102</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTaP-HepB-IPV</vaccineType>
<cvx>110</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTaP-IPV-Hib-HepB, historical</vaccineType>
<cvx>132</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTaP-IPV-Hib-HepB</vaccineType>
<cvx>146</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>HepA-HepB</vaccineType>
<cvx>104</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 2</doseNumber>
<age>
<absMinAge>4 weeks - 4 days</absMinAge>
<minAge>4 weeks</minAge>
<earliestRecAge>2 months</earliestRecAge>
<latestRecAge>3 months + 4 weeks</latestRecAge>
<maxAge/>
</age>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>4 weeks - 4 days</absMinInt>
<minInt>4 weeks</minInt>
<earliestRecInt>4 weeks</earliestRecInt>
<latestRecInt>5 months + 4 weeks</latestRecInt>
<intervalPriority/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>Hep B, Adol/peds</vaccineType>
<cvx>08</cvx>
<beginAge>0 days</beginAge>
<endAge>20 years</endAge>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>DTaP-HepB-IPV</vaccineType>
<cvx>110</cvx>
<beginAge>6 weeks</beginAge>
<endAge>7 years</endAge>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adol/peds</vaccineType>
<cvx>08</cvx>
<beginAge>0 days</beginAge>
<endAge>20 years</endAge>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adol/high risk infant</vaccineType>
<cvx>42</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adult</vaccineType>
<cvx>43</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Dialysis</vaccineType>
<cvx>44</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Unspecified Formulation</vaccineType>
<cvx>45</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hib-HepB</vaccineType>
<cvx>51</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTP-Hib-HepB</vaccineType>
<cvx>102</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTaP-HepB-IPV</vaccineType>
<cvx>110</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTaP-IPV-Hib-HepB, historical</vaccineType>
<cvx>132</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTaP-IPV-Hib-HepB</vaccineType>
<cvx>146</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>HepA-HepB</vaccineType>
<cvx>104</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 3</doseNumber>
<age>
<absMinAge/>
<minAge/>
<earliestRecAge/>
<latestRecAge/>
<maxAge/>
</age>
<interval/>
<allowableInterval/>
<preferableVaccine>
<vaccineType>Hep B, Adol/peds</vaccineType>
<cvx>08</cvx>
<beginAge>0 days</beginAge>
<endAge>20 years</endAge>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>DTaP-HepB-IPV</vaccineType>
<cvx>110</cvx>
<beginAge>6 weeks</beginAge>
<endAge>7 years</endAge>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adol/peds</vaccineType>
<cvx>08</cvx>
<beginAge>0 days</beginAge>
<endAge>20 years</endAge>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adol/high risk infant</vaccineType>
<cvx>42</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adult</vaccineType>
<cvx>43</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Dialysis</vaccineType>
<cvx>44</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Unspecified Formulation</vaccineType>
<cvx>45</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hib-HepB</vaccineType>
<cvx>51</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTP-Hib-HepB</vaccineType>
<cvx>102</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTaP-HepB-IPV</vaccineType>
<cvx>110</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTaP-IPV-Hib-HepB, historical</vaccineType>
<cvx>132</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTaP-IPV-Hib-HepB</vaccineType>
<cvx>146</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>HepA-HepB</vaccineType>
<cvx>104</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 4</doseNumber>
<age>
<absMinAge>24 weeks - 4 days</absMinAge>
<minAge>24 weeks</minAge>
<earliestRecAge>6 months</earliestRecAge>
<latestRecAge>19 months + 4 weeks</latestRecAge>
<maxAge/>
</age>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>8 weeks - 4 days</absMinInt>
<minInt>8 weeks</minInt>
<earliestRecInt/>
<latestRecInt/>
<intervalPriority/>
</interval>
<interval>
<fromPrevious>N</fromPrevious>
<fromTargetDose>1</fromTargetDose>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>16 weeks - 4 days</absMinInt>
<minInt>16 weeks</minInt>
<earliestRecInt/>
<latestRecInt/>
<intervalPriority/>
</interval>
<allowableInterval>
<fromPrevious>N</fromPrevious>
<fromTargetDose>1</fromTargetDose>
<absMinInt>16 weeks - 4 days</absMinInt>
</allowableInterval>
<preferableVaccine>
<vaccineType>Hep B, Adol/peds</vaccineType>
<cvx>08</cvx>
<beginAge>0 days</beginAge>
<endAge>20 years</endAge>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>DTaP-HepB-IPV</vaccineType>
<cvx>110</cvx>
<beginAge>6 weeks</beginAge>
<endAge>7 years</endAge>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adol/peds</vaccineType>
<cvx>08</cvx>
<beginAge>0 days</beginAge>
<endAge>20 years</endAge>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adol/high risk infant</vaccineType>
<cvx>42</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adult</vaccineType>
<cvx>43</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Dialysis</vaccineType>
<cvx>44</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Unspecified Formulation</vaccineType>
<cvx>45</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hib-HepB</vaccineType>
<cvx>51</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTP-Hib-HepB</vaccineType>
<cvx>102</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTaP-HepB-IPV</vaccineType>
<cvx>110</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTaP-IPV-Hib-HepB, historical</vaccineType>
<cvx>132</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTaP-IPV-Hib-HepB</vaccineType>
<cvx>146</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>HepA-HepB</vaccineType>
<cvx>104</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
</series>
<series>
<seriesName>Hep B adolescent 2-dose series</seriesName>
<targetDisease>HepB</targetDisease>
<vaccineGroup>HepB</vaccineGroup>
<seriesAdminGuidance/>
<seriesType>Standard</seriesType>
<equivalentSeriesGroups>2</equivalentSeriesGroups>
<requiredGender/>
<selectSeries>
<defaultSeries>No</defaultSeries>
<productPath>Yes</productPath>
<seriesGroupName>Standard</seriesGroupName>
<seriesGroup>1</seriesGroup>
<seriesPriority>A</seriesPriority>
<seriesPreference>3</seriesPreference>
<minAgeToStart/>
<maxAgeToStart>16 years - 4 months</maxAgeToStart>
</selectSeries>
<indication/>
<seriesDose>
<doseNumber>Dose 1</doseNumber>
<age>
<absMinAge>11 years - 4 days</absMinAge>
<minAge>11 years</minAge>
<earliestRecAge>11 years</earliestRecAge>
<latestRecAge/>
<maxAge/>
</age>
<interval/>
<allowableInterval/>
<preferableVaccine>
<vaccineType>Hep B, Adult</vaccineType>
<cvx>43</cvx>
<beginAge/>
<endAge/>
<tradeName>RECOMBIVAX ADULT</tradeName>
<mvx>MSD</mvx>
<volume>1</volume>
<forecastVaccineType>Y</forecastVaccineType>
</preferableVaccine>
<allowableVaccine/>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 2</doseNumber>
<age>
<absMinAge/>
<minAge/>
<earliestRecAge/>
<latestRecAge/>
<maxAge>16 years</maxAge>
</age>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>4 months - 4 days</absMinInt>
<minInt>4 months</minInt>
<earliestRecInt>4 months</earliestRecInt>
<latestRecInt>7 months + 4 weeks</latestRecInt>
<intervalPriority/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>Hep B, Adult</vaccineType>
<cvx>43</cvx>
<beginAge/>
<endAge/>
<tradeName>RECOMBIVAX ADULT</tradeName>
<mvx>MSD</mvx>
<volume>1</volume>
<forecastVaccineType>Y</forecastVaccineType>
</preferableVaccine>
<allowableVaccine/>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
</series>
<series>
<seriesName>Hep B risk 3-dose series</seriesName>
<targetDisease>HepB</targetDisease>
<vaccineGroup>HepB</vaccineGroup>
<seriesAdminGuidance/>
<seriesType>Risk</seriesType>
<equivalentSeriesGroups>1</equivalentSeriesGroups>
<requiredGender/>
<selectSeries>
<defaultSeries>Yes</defaultSeries>
<productPath>No</productPath>
<seriesGroupName>Increased Risk</seriesGroupName>
<seriesGroup>2</seriesGroup>
<seriesPriority>B</seriesPriority>
<seriesPreference>1</seriesPreference>
<minAgeToStart/>
<maxAgeToStart/>
</selectSeries>
<indication>
<observationCode>
<text>Patient seeks protection</text>
<code>001</code>
</observationCode>
<description>Administer to persons seeking protection.</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Diabetes</text>
<code>014</code>
</observationCode>
<description>Administer to persons who have diabetes.</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance>For patients 60 years and under, vaccinate as soon as feasible after diagnosis, patients over the age of 60 years may be vaccinated</guidance>
</indication>
<indication>
<observationCode>
<text>Chronic liver disease</text>
<code>015</code>
</observationCode>
<description>Administer to persons who have chronic liver disease.</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Men who have sex with men</text>
<code>036</code>
</observationCode>
<description>Administer to men who have sex with men.</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Not in a long-term, mutually monogamous relationship</text>
<code>037</code>
</observationCode>
<description>Administer to persons not in a long-term, mutually monogamous relationship.</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Sex partner of Hepatitis B surface antigen-positive persons</text>
<code>038</code>
</observationCode>
<description>Administer to persons who are a sex partner of a Hepatitis B surface antigen-positive person.</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Receives treatment for STD</text>
<code>039</code>
</observationCode>
<description>Administer to persons who receive treatment for STD.</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Illicit injection drug use</text>
<code>041</code>
</observationCode>
<description>Administer to persons who use illicit injection drugs.</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Health care personnel</text>
<code>055</code>
</observationCode>
<description>Administer to healthcare personnel.</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Public safety worker exposed to blood or infection body fluids</text>
<code>057</code>
</observationCode>
<description>Administer to public safety workers exposed to blood or infection body fluids</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Staff of institution for persons with developmental disabilities</text>
<code>058</code>
</observationCode>
<description>Administer to staff of institution for persons with developmental disabilities</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Client of institution for persons with developmental disabilities</text>
<code>065</code>
</observationCode>
<description>Administer to persons who are a client of institution for persons with developmental disabilities.</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>In drug abuse treatment and prevention facility</text>
<code>068</code>
</observationCode>
<description>Administer to persons who are in a drug abuse treatment and prevention facility.</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>In correctional facility</text>
<code>069</code>
</observationCode>
<description>Administer to persons who are in a correctional facility.</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Household contact with hepatitis B surface antigen-positive persons</text>
<code>071</code>
</observationCode>
<description>Administer to persons who have household contact with hepatitis B surface antigen-positive persons.</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>HIV/AIDS - severely immunocompromised</text>
<code>154</code>
</observationCode>
<description>Administer to persons who have HIV/AIDS and are severely immunocompromised (See the CDC general recommendations for a definition of "severely immunocompromised").</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>HIV/AIDS - not severely immunocompromised</text>
<code>155</code>
</observationCode>
<description>Administer to persons who have HIV/AIDS and are not severely immunocompromised (See the CDC general recommendations for a definition of "severely immunocompromised").</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Chronic renal disease</text>
<code>161</code>
</observationCode>
<description>Administer to persons with chronic renal disease.</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Travel to countries with high or intermediate prevalence of chronic HBV infection</text>
<code>166</code>
</observationCode>
<description>Administered to persons who travel to countries with high or intermediate prevalence of chronic HBV infection.</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<seriesDose>
<doseNumber>Dose 1</doseNumber>
<age>
<absMinAge>0 days</absMinAge>
<minAge>19 years</minAge>
<earliestRecAge>19 years</earliestRecAge>
<latestRecAge/>
<maxAge/>
</age>
<interval/>
<allowableInterval/>
<preferableVaccine>
<vaccineType>Hep B, Adol/peds</vaccineType>
<cvx>08</cvx>
<beginAge>0 days</beginAge>
<endAge>20 years</endAge>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>Hep B, Adult</vaccineType>
<cvx>43</cvx>
<beginAge>20 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>1</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adol/peds</vaccineType>
<cvx>08</cvx>
<beginAge>0 days</beginAge>
<endAge>20 years</endAge>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adol/high risk infant</vaccineType>
<cvx>42</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adult</vaccineType>
<cvx>43</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Dialysis</vaccineType>
<cvx>44</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Unspecified Formulation</vaccineType>
<cvx>45</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hib-HepB</vaccineType>
<cvx>51</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTP-Hib-HepB</vaccineType>
<cvx>102</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTaP-HepB-IPV</vaccineType>
<cvx>110</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTaP-IPV-Hib-HepB, historical</vaccineType>
<cvx>132</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTaP-IPV-Hib-HepB</vaccineType>
<cvx>146</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 2</doseNumber>
<age>
<absMinAge/>
<minAge/>
<earliestRecAge/>
<latestRecAge/>
<maxAge/>
</age>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>4 weeks - 4 days</absMinInt>
<minInt>4 weeks</minInt>
<earliestRecInt>4 weeks</earliestRecInt>
<latestRecInt/>
<intervalPriority/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>Hep B, Adol/peds</vaccineType>
<cvx>08</cvx>
<beginAge>0 days</beginAge>
<endAge>20 years</endAge>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>Hep B, Adult</vaccineType>
<cvx>43</cvx>
<beginAge>20 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>1</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adol/peds</vaccineType>
<cvx>08</cvx>
<beginAge>0 days</beginAge>
<endAge>20 years</endAge>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adol/high risk infant</vaccineType>
<cvx>42</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adult</vaccineType>
<cvx>43</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Dialysis</vaccineType>
<cvx>44</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Unspecified Formulation</vaccineType>
<cvx>45</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hib-HepB</vaccineType>
<cvx>51</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTP-Hib-HepB</vaccineType>
<cvx>102</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTaP-HepB-IPV</vaccineType>
<cvx>110</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTaP-IPV-Hib-HepB, historical</vaccineType>
<cvx>132</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTaP-IPV-Hib-HepB</vaccineType>
<cvx>146</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 3</doseNumber>
<age>
<absMinAge/>
<minAge/>
<earliestRecAge/>
<latestRecAge/>
<maxAge/>
</age>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>8 weeks - 4 days</absMinInt>
<minInt>8 weeks</minInt>
<earliestRecInt>8 weeks</earliestRecInt>
<latestRecInt/>
<intervalPriority/>
</interval>
<interval>
<fromPrevious>N</fromPrevious>
<fromTargetDose>1</fromTargetDose>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>4 months - 4 days</absMinInt>
<minInt>4 months</minInt>
<earliestRecInt/>
<latestRecInt/>
<intervalPriority/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>Hep B, Adol/peds</vaccineType>
<cvx>08</cvx>
<beginAge>0 days</beginAge>
<endAge>20 years</endAge>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>Hep B, Adult</vaccineType>
<cvx>43</cvx>
<beginAge>20 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>1</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adol/peds</vaccineType>
<cvx>08</cvx>
<beginAge>0 days</beginAge>
<endAge>20 years</endAge>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adol/high risk infant</vaccineType>
<cvx>42</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adult</vaccineType>
<cvx>43</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Dialysis</vaccineType>
<cvx>44</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Unspecified Formulation</vaccineType>
<cvx>45</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Hib-HepB</vaccineType>
<cvx>51</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTP-Hib-HepB</vaccineType>
<cvx>102</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTaP-HepB-IPV</vaccineType>
<cvx>110</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTaP-IPV-Hib-HepB, historical</vaccineType>
<cvx>132</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>DTaP-IPV-Hib-HepB</vaccineType>
<cvx>146</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
</series>
<series>
<seriesName>Hep B risk Twinrix 3 Dose Series</seriesName>
<targetDisease>HepB</targetDisease>
<vaccineGroup>HepB</vaccineGroup>
<seriesAdminGuidance/>
<seriesType>Risk</seriesType>
<equivalentSeriesGroups>1</equivalentSeriesGroups>
<requiredGender/>
<selectSeries>
<defaultSeries>No</defaultSeries>
<productPath>Yes</productPath>
<seriesGroupName>Increased Risk</seriesGroupName>
<seriesGroup>2</seriesGroup>
<seriesPriority>B</seriesPriority>
<seriesPreference>2</seriesPreference>
<minAgeToStart>19 years</minAgeToStart>
<maxAgeToStart/>
</selectSeries>
<indication>
<observationCode>
<text>Patient seeks protection</text>
<code>001</code>
</observationCode>
<description>Administer to persons seeking protection.</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Diabetes</text>
<code>014</code>
</observationCode>
<description>Administer to persons  who have diabetes.</description>
<beginAge>19 years</beginAge>
<endAge>60 years</endAge>
<guidance>Vaccinate as soon as feasible after diagnosis</guidance>
</indication>
<indication>
<observationCode>
<text>Chronic liver disease</text>
<code>015</code>
</observationCode>
<description>Administer to persons who have chronic liver disease.</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Men who have sex with men</text>
<code>036</code>
</observationCode>
<description>Administer to men who have sex with men.</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Not in a long-term, mutually monogamous relationship</text>
<code>037</code>
</observationCode>
<description>Adminster to persons not in a long-term, mutually monogamous relationship.</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Sex partner of Hepatitis B surface antigen-positive persons</text>
<code>038</code>
</observationCode>
<description>Adminster to persons who are a sex partner of a Hepatitis B surface antigen-positive person.</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Receives treatment for STD</text>
<code>039</code>
</observationCode>
<description>Administer to persons who receive treatment for STD.</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Illicit injection drug use</text>
<code>041</code>
</observationCode>
<description>Administer to persons who use illicit injection drugs.</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Health care personnel</text>
<code>055</code>
</observationCode>
<description>Administer to  healthcare personnel.</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Public safety worker exposed to blood or infection body fluids</text>
<code>057</code>
</observationCode>
<description>Administer to public safety workers exposed to blood or infection body fluids</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Staff of institution for persons with developmental disabilities</text>
<code>058</code>
</observationCode>
<description>Administer to staff of institution for persons with developmental disabilities</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Client of institution for persons with developmental disabilities</text>
<code>065</code>
</observationCode>
<description>Administer to persons who are a client of institution for persons with developmental disabilities.</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>In drug abuse treatment and prevention facility</text>
<code>068</code>
</observationCode>
<description>Administer to persons who are in a drug abuse treatment and prevention facility.</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>In correctional facility</text>
<code>069</code>
</observationCode>
<description>Administer to persons who are in a correctional facility.</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Household contact with hepatitis B surface antigen-positive persons</text>
<code>071</code>
</observationCode>
<description>Administer to persons who have household contact with hepatitis B surface antigen-positive persons.</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>HIV/AIDS - severely immunocompromised</text>
<code>154</code>
</observationCode>
<description>Administer to persons who have HIV/AIDS and are severely immunocompromised (See the CDC general recommendations for a definition of "severely  immunocompromised").</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>HIV/AIDS - not severely immunocompromised</text>
<code>155</code>
</observationCode>
<description>Administer to persons who have HIV/AIDS and are not severely immunocompromised (See the CDC general recommendations for a definition of "severely  immunocompromised").</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Chronic renal disease</text>
<code>161</code>
</observationCode>
<description>Administer to persons with chronic renal disease.</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Travel to countries with high or intermediate prevalence of chronic HBV infection</text>
<code>166</code>
</observationCode>
<description>Administered to persons who travel to countries with high or intermediate prevalence of chronic HBV infection.</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<seriesDose>
<doseNumber>Dose 1</doseNumber>
<age>
<absMinAge>19 years - 4 days</absMinAge>
<minAge>19 years</minAge>
<earliestRecAge>19 years</earliestRecAge>
<latestRecAge/>
<maxAge/>
</age>
<interval/>
<allowableInterval/>
<preferableVaccine>
<vaccineType>HepA-HepB</vaccineType>
<cvx>104</cvx>
<beginAge>18 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>1</volume>
<forecastVaccineType>Y</forecastVaccineType>
</preferableVaccine>
<allowableVaccine/>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 2</doseNumber>
<age>
<absMinAge/>
<minAge/>
<earliestRecAge/>
<latestRecAge/>
<maxAge/>
</age>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>4 weeks - 4 days</absMinInt>
<minInt>4 weeks</minInt>
<earliestRecInt>4 weeks</earliestRecInt>
<latestRecInt/>
<intervalPriority/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>HepA-HepB</vaccineType>
<cvx>104</cvx>
<beginAge>18 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>1</volume>
<forecastVaccineType>Y</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adult</vaccineType>
<cvx>43</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>HepA-HepB</vaccineType>
<cvx>104</cvx>
<beginAge>18 years - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 3</doseNumber>
<age>
<absMinAge/>
<minAge/>
<earliestRecAge/>
<latestRecAge/>
<maxAge/>
</age>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>5 months - 4 days</absMinInt>
<minInt>5 months</minInt>
<earliestRecInt>5 months</earliestRecInt>
<latestRecInt/>
<intervalPriority/>
</interval>
<interval>
<fromPrevious>N</fromPrevious>
<fromTargetDose>1</fromTargetDose>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>6 months</absMinInt>
<minInt>6 months</minInt>
<earliestRecInt>6 months</earliestRecInt>
<latestRecInt/>
<intervalPriority/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>HepA-HepB</vaccineType>
<cvx>104</cvx>
<beginAge>18 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>1</volume>
<forecastVaccineType>Y</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adult</vaccineType>
<cvx>43</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>HepA-HepB</vaccineType>
<cvx>104</cvx>
<beginAge>18 years - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
</series>
<series>
<seriesName>Hep B risk Twinrix 4-dose series</seriesName>
<targetDisease>HepB</targetDisease>
<vaccineGroup>HepB</vaccineGroup>
<seriesAdminGuidance/>
<seriesType>Risk</seriesType>
<equivalentSeriesGroups>1</equivalentSeriesGroups>
<requiredGender/>
<selectSeries>
<defaultSeries>No</defaultSeries>
<productPath>Yes</productPath>
<seriesGroupName>Increased Risk</seriesGroupName>
<seriesGroup>2</seriesGroup>
<seriesPriority>B</seriesPriority>
<seriesPreference>3</seriesPreference>
<minAgeToStart>19 years</minAgeToStart>
<maxAgeToStart/>
</selectSeries>
<indication>
<observationCode>
<text>Patient seeks protection</text>
<code>001</code>
</observationCode>
<description>Administer to persons seeking protection.</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Diabetes</text>
<code>014</code>
</observationCode>
<description>Administer to persons  who have diabetes.</description>
<beginAge>19 years</beginAge>
<endAge>60 years</endAge>
<guidance>Vaccinate as soon as feasible after diagnosis</guidance>
</indication>
<indication>
<observationCode>
<text>Chronic liver disease</text>
<code>015</code>
</observationCode>
<description>Administer to persons who have chronic liver disease.</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Men who have sex with men</text>
<code>036</code>
</observationCode>
<description>Administer to men who have sex with men.</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Not in a long-term, mutually monogamous relationship</text>
<code>037</code>
</observationCode>
<description>Adminster to persons not in a long-term, mutually monogamous relationship.</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Sex partner of Hepatitis B surface antigen-positive persons</text>
<code>038</code>
</observationCode>
<description>Adminster to persons who are a sex partner of a Hepatitis B surface antigen-positive person.</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Receives treatment for STD</text>
<code>039</code>
</observationCode>
<description>Administer to persons who receive treatment for STD.</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Illicit injection drug use</text>
<code>041</code>
</observationCode>
<description>Administer to persons who use illicit injection drugs.</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Health care personnel</text>
<code>055</code>
</observationCode>
<description>Administer to  healthcare personnel.</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Public safety worker exposed to blood or infection body fluids</text>
<code>057</code>
</observationCode>
<description>Administer to public safety workers exposed to blood or infection body fluids</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Staff of institution for persons with developmental disabilities</text>
<code>058</code>
</observationCode>
<description>Administer to staff of institution for persons with developmental disabilities</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Client of institution for persons with developmental disabilities</text>
<code>065</code>
</observationCode>
<description>Administer to persons who are a client of institution for persons with developmental disabilities.</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>In drug abuse treatment and prevention facility</text>
<code>068</code>
</observationCode>
<description>Administer to persons who are in a drug abuse treatment and prevention facility.</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>In correctional facility</text>
<code>069</code>
</observationCode>
<description>Administer to persons who are in a correctional facility.</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Household contact with hepatitis B surface antigen-positive persons</text>
<code>071</code>
</observationCode>
<description>Administer to persons who have household contact with hepatitis B surface antigen-positive persons.</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>HIV/AIDS - severely immunocompromised</text>
<code>154</code>
</observationCode>
<description>Administer to persons who have HIV/AIDS and are severely immunocompromised (See the CDC general recommendations for a definition of "severely  immunocompromised").</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>HIV/AIDS - not severely immunocompromised</text>
<code>155</code>
</observationCode>
<description>Administer to persons who have HIV/AIDS and are not severely immunocompromised (See the CDC general recommendations for a definition of "severely  immunocompromised").</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Chronic renal disease</text>
<code>161</code>
</observationCode>
<description>Administer to persons with chronic renal disease.</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Travel to countries with high or intermediate prevalence of chronic HBV infection</text>
<code>166</code>
</observationCode>
<description>Administered to persons who travel to countries with high or intermediate prevalence of chronic HBV infection.</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<seriesDose>
<doseNumber>Dose 1</doseNumber>
<age>
<absMinAge>19 years - 4 days</absMinAge>
<minAge>19 years</minAge>
<earliestRecAge>19 years</earliestRecAge>
<latestRecAge/>
<maxAge/>
</age>
<interval/>
<allowableInterval/>
<preferableVaccine>
<vaccineType>HepA-HepB</vaccineType>
<cvx>104</cvx>
<beginAge>18 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>1</volume>
<forecastVaccineType>Y</forecastVaccineType>
</preferableVaccine>
<allowableVaccine/>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 2</doseNumber>
<age>
<absMinAge/>
<minAge/>
<earliestRecAge/>
<latestRecAge/>
<maxAge/>
</age>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>7 days</absMinInt>
<minInt>7 days</minInt>
<earliestRecInt>7 days</earliestRecInt>
<latestRecInt/>
<intervalPriority/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>HepA-HepB</vaccineType>
<cvx>104</cvx>
<beginAge>18 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>1</volume>
<forecastVaccineType>Y</forecastVaccineType>
</preferableVaccine>
<allowableVaccine/>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 3</doseNumber>
<age>
<absMinAge/>
<minAge/>
<earliestRecAge/>
<latestRecAge/>
<maxAge/>
</age>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>14 days</absMinInt>
<minInt>14 days</minInt>
<earliestRecInt>14 days</earliestRecInt>
<latestRecInt>23 days</latestRecInt>
<intervalPriority/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>HepA-HepB</vaccineType>
<cvx>104</cvx>
<beginAge>18 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>1</volume>
<forecastVaccineType>Y</forecastVaccineType>
</preferableVaccine>
<allowableVaccine/>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 4</doseNumber>
<age>
<absMinAge/>
<minAge/>
<earliestRecAge/>
<latestRecAge/>
<maxAge/>
</age>
<interval>
<fromPrevious>N</fromPrevious>
<fromTargetDose>1</fromTargetDose>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>12 months - 4 days</absMinInt>
<minInt>12 months</minInt>
<earliestRecInt>12 months</earliestRecInt>
<latestRecInt/>
<intervalPriority/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>HepA-HepB</vaccineType>
<cvx>104</cvx>
<beginAge>18 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>1</volume>
<forecastVaccineType>Y</forecastVaccineType>
</preferableVaccine>
<allowableVaccine/>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
</series>
<series>
<seriesName>Hep B risk Recombivax 3-dose series</seriesName>
<targetDisease>HepB</targetDisease>
<vaccineGroup>HepB</vaccineGroup>
<seriesAdminGuidance/>
<seriesType>Risk</seriesType>
<equivalentSeriesGroups>1</equivalentSeriesGroups>
<requiredGender/>
<selectSeries>
<defaultSeries>No</defaultSeries>
<productPath>Yes</productPath>
<seriesGroupName>Increased Risk</seriesGroupName>
<seriesGroup>2</seriesGroup>
<seriesPriority>A</seriesPriority>
<seriesPreference/>
<minAgeToStart>19 years</minAgeToStart>
<maxAgeToStart/>
</selectSeries>
<indication>
<observationCode>
<text>End stage renal disease</text>
<code>114</code>
</observationCode>
<description>Administer to persons who have end stage renal disease.</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<seriesDose>
<doseNumber>Dose 1</doseNumber>
<age>
<absMinAge>19 years - 4 days</absMinAge>
<minAge>19 years</minAge>
<earliestRecAge/>
<latestRecAge/>
<maxAge/>
</age>
<interval/>
<allowableInterval/>
<preferableVaccine>
<vaccineType>Hep B, Dialysis</vaccineType>
<cvx>44</cvx>
<beginAge>19 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>1</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Dialysis</vaccineType>
<cvx>44</cvx>
<beginAge>19 years - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 2</doseNumber>
<age>
<absMinAge/>
<minAge/>
<earliestRecAge/>
<latestRecAge/>
<maxAge/>
</age>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>4 weeks - 4 days</absMinInt>
<minInt>4 weeks</minInt>
<earliestRecInt>4 weeks</earliestRecInt>
<latestRecInt/>
<intervalPriority/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>Hep B, Dialysis</vaccineType>
<cvx>44</cvx>
<beginAge>20 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>1</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Dialysis</vaccineType>
<cvx>44</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 3</doseNumber>
<age>
<absMinAge/>
<minAge/>
<earliestRecAge/>
<latestRecAge/>
<maxAge/>
</age>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>5 months - 4 days</absMinInt>
<minInt>5 months</minInt>
<earliestRecInt>5 months</earliestRecInt>
<latestRecInt/>
<intervalPriority/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>Hep B, Dialysis</vaccineType>
<cvx>44</cvx>
<beginAge>20 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>1</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Dialysis</vaccineType>
<cvx>44</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
</series>
<series>
<seriesName>Hep B risk Engerix-B 3-dose series</seriesName>
<targetDisease>HepB</targetDisease>
<vaccineGroup>HepB</vaccineGroup>
<seriesAdminGuidance/>
<seriesType>Risk</seriesType>
<equivalentSeriesGroups>1</equivalentSeriesGroups>
<requiredGender/>
<selectSeries>
<defaultSeries>No</defaultSeries>
<productPath>Yes</productPath>
<seriesGroupName>Increased Risk</seriesGroupName>
<seriesGroup>2</seriesGroup>
<seriesPriority>A</seriesPriority>
<seriesPreference/>
<minAgeToStart>19 years</minAgeToStart>
<maxAgeToStart/>
</selectSeries>
<indication>
<observationCode>
<text>End stage renal disease</text>
<code>114</code>
</observationCode>
<description>Administer to persons who have end stage renal disease.</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<seriesDose>
<doseNumber>Dose 1</doseNumber>
<age>
<absMinAge>19 years- 4 days</absMinAge>
<minAge>19 years</minAge>
<earliestRecAge/>
<latestRecAge/>
<maxAge/>
</age>
<interval/>
<allowableInterval/>
<preferableVaccine>
<vaccineType>Hep B, Adult</vaccineType>
<cvx>43</cvx>
<beginAge>19 years - 4 days</beginAge>
<endAge/>
<tradeName>ENGERIX-B ADULT</tradeName>
<mvx>SKB</mvx>
<volume>2</volume>
<forecastVaccineType>Y</forecastVaccineType>
</preferableVaccine>
<allowableVaccine/>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 2</doseNumber>
<age>
<absMinAge/>
<minAge/>
<earliestRecAge/>
<latestRecAge/>
<maxAge/>
</age>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>4 weeks - 4 days</absMinInt>
<minInt>4 weeks</minInt>
<earliestRecInt>4 weeks</earliestRecInt>
<latestRecInt/>
<intervalPriority/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>Hep B, Adult</vaccineType>
<cvx>43</cvx>
<beginAge>19 years</beginAge>
<endAge/>
<tradeName>ENGERIX-B ADULT</tradeName>
<mvx>SKB</mvx>
<volume>2</volume>
<forecastVaccineType>Y</forecastVaccineType>
</preferableVaccine>
<allowableVaccine/>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 3</doseNumber>
<age>
<absMinAge/>
<minAge/>
<earliestRecAge/>
<latestRecAge/>
<maxAge/>
</age>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>4 weeks - 4 days</absMinInt>
<minInt>4 weeks</minInt>
<earliestRecInt>4 weeks</earliestRecInt>
<latestRecInt/>
<intervalPriority/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>Hep B, Adult</vaccineType>
<cvx>43</cvx>
<beginAge>19 years</beginAge>
<endAge/>
<tradeName>ENGERIX-B ADULT</tradeName>
<mvx>SKB</mvx>
<volume>2</volume>
<forecastVaccineType>Y</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>Hep B, Adult</vaccineType>
<cvx>43</cvx>
<beginAge>0 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 4</doseNumber>
<age>
<absMinAge/>
<minAge/>
<earliestRecAge/>
<latestRecAge/>
<maxAge/>
</age>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>4 months - 4 days</absMinInt>
<minInt>4 months</minInt>
<earliestRecInt>4 months</earliestRecInt>
<latestRecInt/>
<intervalPriority/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>Hep B, Adult</vaccineType>
<cvx>43</cvx>
<beginAge>19 years</beginAge>
<endAge/>
<tradeName>ENGERIX-B ADULT</tradeName>
<mvx>SKB</mvx>
<volume>2</volume>
<forecastVaccineType>Y</forecastVaccineType>
</preferableVaccine>
<allowableVaccine/>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
</series>
</antigenSupportingData>
